ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Gimv NV

Gimv NV (GIMB)

37.75
-2.65
( -6.56% )
Actualizado: 06:46:54

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
37.75
Postura de Compra
37.70
Postura de Venta
37.75
Volume Operado de la Acción
39,845
37.55 Rango del Día 39.80
36.60 Rango de 52 semanas 47.10
Capitalización de Mercado [m]
Precio Anterior
40.40
Precio de Apertura
39.80
Última hora de negociación
06:52:33
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
20,459
Acciones en circulación
27,872,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
4.85
Beneficio por acción (BPA)
7.79
turnover
1.57M
Beneficio neto
217.13M

Acerca de Gimv NV

Sector
Security Brokers & Dealers
Industria
Security Brokers & Dealers
Sitio web
Sede
Antwerp, Antwerp, Bel
Fundado
-
Gimv NV is listed in the Security Brokers & Dealers sector of the Euronext with ticker GIMB. The last closing price for Gimv NV was 40.40 €. Over the last year, Gimv NV shares have traded in a share price range of 36.60 € to 47.10 €.

Gimv NV currently has 27,872,000 shares in issue. The market capitalisation of Gimv NV is 1.13 € billion. Gimv NV has a price to earnings ratio (PE ratio) of 4.85.

GIMB Últimas noticias

JenaValve Technology Welcomes Jane Metcalf as Vice President, Regulatory Affairs and Quality

IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve replacement (TAVR) systems for...

JenaValve Raises $62.5 Million In Venture Funding

JenaValve Raises $62.5 Million In Venture Funding Capital to Fund Clinical Study for Transfemoral TAVI system, Expansion of Commercial Initiatives PR Newswire WILMINGTON, Del. and MUNICH, July...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.25-3.205128205133939.937.552426039.35599817DE
4-1.75-4.4303797468439.54137.551964639.76475192DE
12-0.4-1.0484927916138.1541.636.62045939.33696795DE
26-3.2-7.8144078144140.9543.436.61710139.94455931DE
52-6-13.714285714343.7547.136.61639141.99154517DE
156-15.05-28.503787878852.856.336.151541044.31295925DE
260-18.85-33.303886925856.659.436.151496446.86681435DE

GIMB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Gimv NV?
El precio actual de las acciones de Gimv NV es 37.75 €
¿Cuántas acciones de Gimv NV están en circulación?
Gimv NV tiene 27,872,000 acciones en circulación
¿Cuál es la capitalización de mercado de Gimv NV?
La capitalización de mercado de Gimv NV es EUR 1.13B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Gimv NV?
Gimv NV ha negociado en un rango de 36.60 € a 47.10 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Gimv NV?
El ratio precio/beneficio de Gimv NV es 4.85
¿Cuál es el ratio de efectivo a ventas de Gimv NV?
El ratio de efectivo a ventas de Gimv NV es 668.14
¿Cuál es la moneda de reporte de Gimv NV?
Gimv NV presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Gimv NV?
El último ingresos anual de Gimv NV es EUR 1.57M
¿Cuál es el último beneficio anual de Gimv NV?
El último beneficio anual de Gimv NV es EUR 217.13M
¿Cuál es la dirección registrada de Gimv NV?
La dirección registrada de Gimv NV es KAREL OOMSSTRAAT 37, ANTWERP, ANTWERP, 2018
¿Cuál es la dirección del sitio web de Gimv NV?
La dirección del sitio web de Gimv NV es www.gimv.com
¿En qué sector industrial opera Gimv NV?
Gimv NV opera en el sector SECURITY BROKERS & DEALERS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNMRNamR SA
0.48 €
(118.18%)
172.3k
MLGEQGentlemen S Equity SA
0.0295 €
(34.09%)
9.18k
GNROGeNeuro SA
0.1815 €
(27.82%)
897.37k
FORSEForsee Power SA
0.72 €
(17.84%)
507.75k
VACBSPierre & Vacances
0.06 €
(16.73%)
72.41k
MLERHElix Rental Housing Socimi ii SA
2.00 €
(-90.00%)
1
ALCYBCybergun
0.0001 €
(-50.00%)
5.02M
MLAAHAmatheon Agri Holding NV
0.0195 €
(-32.76%)
1
ALNEVNeovacs
0.39 €
(-21.83%)
20.75k
ALSPWSpineway
0.1089 €
(-17.50%)
2.17M
ATOAtos SE
0.0021 €
(0.00%)
257.21M
BCPBanco Comercial Portugues SA
0.5104 €
(0.24%)
42.58M
ALVERVergnet
0.0016 €
(0.00%)
22.81M
ALMASMastrad
0.023 €
(9.52%)
17.11M
BIOSBiosenic
0.0049 €
(-5.77%)
8.75M
glenn1919 glenn1919 4 minutos hace
MDAI......MBOT........VERU.........BNZI.........MULN.................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
BNZI MBOT MDAI
georgie18 georgie18 4 minutos hace
GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1
GNPX
georgie18 georgie18 4 minutos hace
GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1
GNPX
dexprs dexprs 4 minutos hace
Looking at the Put Call Ratio, I see that the smart money is looking for a pull back as they were buying Puts a little below the recent highs in the technology sector and the large caps that ran up the most.
I will taper my planned purchases by 1/3.
The 10YT yield is heading up slowly
nowwhat2 nowwhat2 5 minutos hace
https://investorshub.advfn.com/uimage/uploads/2025/1/22/gxmfybtc_!_22_capt_8pm_WT_MAGIC.jpg

https://investorshub.advfn.com/uimage/uploads/2025/1/22/jdzuyBTC_!_22_1M_6pm_100k_ON_DIAG.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/22/ulhfvBTC_!_22_1M_612
BTCUSD
georgie18 georgie18 5 minutos hace
GNPX...76...Added on News...🥳...https://www.prnewswire.com/news-releases/genprex-announces-first-patient-dosed-in-phase-2-expansion-portion-of-acclaim-3-clinical-study-of-reqorsa-gene-therapy-in-combination-with-tecentriq-to-treat-small-cell-lung-cancer-302358445.html

georgie1
GNPX
georgejjl georgejjl 5 minutos hace
News next week regarding a new potentially pivotal trial for treatment of Parkinson’s disease with Anavex’s blarcamesine.

Good luck and GOD bless,
AVXL
wadegarret wadegarret 5 minutos hace
updated

GERN 70000 shares

Cash $35764
GERN
budfoxfun budfoxfun 5 minutos hace
The television advertising will showcase SGTM's brand on major networks such as ESPN2, THE DISCOVERY CHANNEL, PURSUIT NETWORK, WFN, ATT SPORTS SW, and other networks as they become available.
SGTM
LandPro LandPro 5 minutos hace
With No substance, no communication, and no game plan, I highly doubt these slant-eyed scamming communist chinamen can pull off another pump and dump. Even the real pumpers are MIA. There are zero reasons to buy this garbage, which is obvious. FFS😆
IGPK
Real McCoy Real McCoy 6 minutos hace
This is dead, right? Liquidation 6 years ago?
joe_techi joe_techi 6 minutos hace
“For so long, people were like, ‘You can't do work in pain, because everything fails,’” CBO James Hackworth, told Fierce. “Now, after decades of nothing new, it looks like we're on the cusp of two things that are very new that will succeed.”

Tris Pharma's alternative to opioids reduce
NPHC
bones jones bones jones 6 minutos hace
It is halted
https://www.otcmarkets.com/stock/TWOH/security

TWOH
budfoxfun budfoxfun 6 minutos hace
A key product in SGTM's portfolio, HumiSoil is a patented formula invented by VRM Biologik designed to replenish organic nutrients and water solubility in depleted soils. In today's agricultural practices, soil often loses vital nutrients, leading to reduced crop yields and hampering carbon dioxide
SGTM
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutos hace
You were the one pumping "contracts".  Than you went silent about it.

Funny how that works. 
MONI
Here Today Here Today 7 minutos hace
One day, we might wake up to an amazing PR that sees this stocks share price skyrocket higher like never before......
VDRM
glenn1919 glenn1919 7 minutos hace
LITM.........PLRZ.......TNXP.........MULN.....................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
LITM MULN PLRZ
wadegarret wadegarret 7 minutos hace
Sell SOXS @ $17.51

Sell 2000 SOXS @ $17.51 = $35020
SOXS
Invest-in-America Invest-in-America 8 minutos hace
VINC: Love it!!!
VINC
Hoskuld Hoskuld 8 minutos hace
ChatGPT doesn't know anything about the SAP because it doesn't have access to the SAP. No one does outside of Anavex and those under NDA.
AVXL
timberwolf7 timberwolf7 8 minutos hace
Be patient, IF this is as good a development as it 'appears', it will
take care of itself.

Have to remember, Rome wasn't built in a day either..

Let it move, and look for it to build a staircase of
support levels. As long as it keeps doing that between
TNXP
mascale mascale 8 minutos hace
Then comparing, data-free posts of Hiru detractors fail even at data-free(?): "In polling, "No response" answers are typically recorded as a separate category in the data, often designated by a unique code (like "9" or "NR") which allows researchers to differentiate them from other answer choices w
HIRU
georgie18 georgie18 8 minutos hace
Just check my history...🥳....you will find plenty...not gonna list them all but here are a few ...GNPX...from .47 to $4...MNPR...from $5 range to $40 range...QMCO...from $6 range to $90...I never hold to the very top but they did run well...
GNPX MNPR QMCO
budfoxfun budfoxfun 8 minutos hace
$IVDN Banging News!! Innovative Designs, Inc. Welcomes Experienced Real Estate Developer With Relations to Top Homebuilding Names Including D.R. Horton, NVR / Ryan Homes and More

https://www.newmediawire.com/news/innovative-designs-inc-welcomes-experienced-real-estate-developer-with-
IVDN

Su Consulta Reciente

Delayed Upgrade Clock